Piper Jaffray Remains Sidelined on Teva Pharma (TEVA) Following 1Q - PT to $58
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Adamis Pharmaceuticals Announces License Agreement with Allergan plc Subsidiary for Epinephrine Pre-Filled Syringe
May 10, 2016 6:45 AM EDTDUBLIN, Ireland and SAN DIEGO, May 10, 2016 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (Adamis) has entered into an exclusive licensing agreement with Allergan plcs wholly owned subsidiary, Watson Laboratories, Inc. (Watson), to commercialize Adamis Epinephrine Pre-filled Syringe (PFS) product candidate for the emergency treatment of anaphylaxis.
Under the terms of the agreement, Watson will obtain commercial rights for the U.S. in exchange for an upfront fee and potential regulatory and performance based milestone payments totaling up to $32.5 million. Additionally, Watson will pay double-digit royalties to Adamis based on... More
Teva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
May 9, 2016 11:00 AM EDTJERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Bank of America Merrill Lynch 2016 Health Care Conference. Siggi Olafsson will present on Tuesday, May 10, 2016 at 8:40 AM PT.
ÂWhat:
   Teva Presentation at the Bank of America Merrill Lynch Healthcare Conference ÂWho:
Siggi Olafsson, President and CEO, Global Generic Medicines,Â
Teva Pharmaceutical Industries Ltd.
 ... MoreTeva Reports First Quarter 2016 Results
May 9, 2016 7:00 AM EDTJERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended March 31, 2016.
   Q1 2016  Revenues $4.81 billion Cash flow from Operations $1.38 billion Non-GAAP EPS $1.20 GAAP EPS $0.62... More